195 related articles for article (PubMed ID: 34121219)
1. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
[TBL] [Abstract][Full Text] [Related]
2. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
[TBL] [Abstract][Full Text] [Related]
3. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
[TBL] [Abstract][Full Text] [Related]
4. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
[TBL] [Abstract][Full Text] [Related]
5. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
[TBL] [Abstract][Full Text] [Related]
6. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
Johnson C; Parsa L; Gibbs J; Sligh J
J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
[TBL] [Abstract][Full Text] [Related]
8. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
[TBL] [Abstract][Full Text] [Related]
9. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
Bruce-Brand C; Conradie W; Schneider JW
Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
[TBL] [Abstract][Full Text] [Related]
10. Superficial CD34-positive fibroblastic tumor in the forearm of a middle-aged patient: A newly described, rare soft-tissue tumor.
Rekhi B; Banerjee D; Gala K; Gulia A
Indian J Pathol Microbiol; 2018; 61(3):421-424. PubMed ID: 30004071
[TBL] [Abstract][Full Text] [Related]
11. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review.
Li SY; Zhang HL; Bai YZ
Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506
[TBL] [Abstract][Full Text] [Related]
12. GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial differentiation, and a predilection for children and young adults.
Agaimy A; Perret R; Demicco EG; Gross J; Liu YJ; Azmani R; Engelmann C; Schubart C; Seppet J; Stoehr R; Le Loarer F; Dickson BC
Genes Chromosomes Cancer; 2023 Aug; 62(8):449-459. PubMed ID: 36744864
[TBL] [Abstract][Full Text] [Related]
13. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors.
Shaker N; Abu Shakra R; Sangueza OP
Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590
[TBL] [Abstract][Full Text] [Related]
14. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
15. Superficial CD34-Positive Fibroblastic Tumor.
Perret R; Hostein I
Surg Pathol Clin; 2024 Mar; 17(1):1-12. PubMed ID: 38278599
[TBL] [Abstract][Full Text] [Related]
16. Superficial CD34-Positive Fibroblastic Tumor.
Foot O; Hallin M; Bagué S; Jones RL; Thway K
Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310
[TBL] [Abstract][Full Text] [Related]
17. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases.
Hollmann TJ; Bovée JV; Fletcher CD
Am J Surg Pathol; 2012 Jun; 36(6):789-98. PubMed ID: 22367301
[TBL] [Abstract][Full Text] [Related]
18. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
19. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
20. Superficial mesenchymal tumours expressing epithelial markers on immunohistochemistry: Diagnostic clues and pitfalls.
Andrei V; Haefliger S; Baumhoer D
Semin Diagn Pathol; 2023 Jul; 40(4):238-245. PubMed ID: 37147159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]